Applications for Novel or New Molecular Entities (NMEs) - treatments that have never been approved by the FDA- are on the decline, while me-too drugs are increasing and so are costs.

Burckle, it beats me how the larger drug companies can complain about costs. Amgen is all over the world, they have money to burn. Something takes over when that kind of wealth is involved and I don't' think it's compassion for the sick.

THanks for the article tip. Isn't she the one that wrote an excellent book about the pharmas?

Paula